Artículo
Genetic alterations and deregulation of hippo pathway as a pathogenetic mechanism in bone and soft tissue sarcoma
Autor/es | Salguero-Aranda, Carmen
Olmedo Pelayo, Joaquín Álava Casado, Enrique de Amaral, Ana Teresa Díaz-Martín, Juan |
Departamento | Universidad de Sevilla. Departamento de Citología e Histología Normal y Patológica |
Fecha de publicación | 2022 |
Fecha de depósito | 2023-03-31 |
Publicado en |
|
Resumen | The Hippo pathway is an evolutionarily conserved modulator of developmental biology
with a key role in tissue and organ size regulation under homeostatic conditions. Like other signaling
pathways with a significant role ... The Hippo pathway is an evolutionarily conserved modulator of developmental biology with a key role in tissue and organ size regulation under homeostatic conditions. Like other signaling pathways with a significant role in embryonic development, the deregulation of Hippo signaling contributes to oncogenesis. Central to the Hippo pathway is a conserved cascade of adaptor proteins and inhibitory kinases that converge and regulate the activity of the oncoproteins YAP and TAZ, the final transducers of the pathway. Elevated levels and aberrant activation of YAP and TAZ have been described in many cancers. Though most of the studies describe their pervasive activation in epithelial neoplasms, there is increasing evidence pointing out its relevance in mesenchymal malignancies as well. Interestingly, somatic or germline mutations in genes of the Hippo pathway are scarce compared to other signaling pathways that are frequently disrupted in cancer. However, in the case of sarcomas, several examples of genetic alteration of Hippo members, including gene fusions, have been described during the last few years. Here, we review the current knowledge of Hippo pathway implication in sarcoma, describing mechanistic hints recently reported in specific histological entities and how these alterations represent an opportunity for targeted therapy in this heterogeneous group of neoplasm. |
Identificador del proyecto | PE-0186-2018 |
Cita | Salguero-Aranda, C., Olmedo Pelayo, J., Álava Casado, E.d., Amaral, A.T. y Díaz-Martín, J. (2022). Genetic alterations and deregulation of hippo pathway as a pathogenetic mechanism in bone and soft tissue sarcoma. Cancers, 14 (24), 6211. https://doi.org/10.3390/cancers14246211. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
Genetic Alterations...pdf | 913.4Kb | [PDF] | Ver/ | |